Determination of the antihypertensive drug cilazapril and its active metabolite cilazaprilat in pharmaceuticals and urine by solid-phase extraction and high-performance liquid chromatography with photometric detection.
A liquid chromatographic method with photometric detection for the determination of cilazapril and its active metabolite and degradation product cilazaprilat in urine and pharmaceuticals has been developed. The chromatographic method consisted of a microBondapak C18 column maintained at 30+/-0.2 degrees C, using a mixture of methanol-10 mM phosphoric acid (50:50 v/v) as mobile phase at a flow-rate of 1.0 ml/min. Enalapril maleate was used as internal standard. The detection was performed at a wavelength of 206 nm. A study of the retention of cilazapril and cilazaprilat using solid-liquid extraction has been carried out in order to optimise the clean-up procedure for urine samples, which consisted of a solid-liquid extraction using C(R) cartridges. Recoveries greater than 85% are obtained for both compounds. The method was sensitive, precise and accurate enough to be applied to the determination of urine samples obtained from three hypertensive patients up to 24 h after intake of a therapeutic dose (detection limit of 70 ng/ml for cilazapril and cilazaprilat in urine). A comparison of the method developed using photometric and amperometric detection has been carried out.
Prieto
J A
JA
Departamento de Química Analítica, Facultad de Ciencias, Universidad del País Vasco, Bilbao, Spain.
Jiménez
R M
RM
Alonso
R M
RM
Ortiz
E
E
D000959:Antihypertensive Agents / Q000032:analysis* / Q000627:therapeutic use / Q000652:urine; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D017315:Cilazapril / Q000031:analogs & derivatives / Q000032:analysis* / Q000627:therapeutic use / Q000652:urine; D004563:Electrochemistry; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D015394:Molecular Structure; D010783:Photometry
D000959:Antihypertensive Agents; D017315:Cilazapril; C045980:cilazaprilat